NLRP3 and Parkinson disease: Moreover, Parkin deficiency exacerbates microglia activation and neurodegeneration in LPS‐induced PD mice, thus indicating that promoting Parkin activity may represent a strategy for inhibiting NLRP3‐related neuroinflammation to treat PD.